ATE189388T1 - Biologisch aktive ureido-derivate nützlich zur behandlung von multipler sklerose - Google Patents

Biologisch aktive ureido-derivate nützlich zur behandlung von multipler sklerose

Info

Publication number
ATE189388T1
ATE189388T1 AT97904356T AT97904356T ATE189388T1 AT E189388 T1 ATE189388 T1 AT E189388T1 AT 97904356 T AT97904356 T AT 97904356T AT 97904356 T AT97904356 T AT 97904356T AT E189388 T1 ATE189388 T1 AT E189388T1
Authority
AT
Austria
Prior art keywords
biologically active
multiple sclerosis
derivatives useful
treating multiple
ureido derivatives
Prior art date
Application number
AT97904356T
Other languages
English (en)
Inventor
Rachele Alzani
Elena Cozzi
Nicola Mongelli
Andrea Lombardi Borgia
Massimo Temponi
Francesco Colotta
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Application granted granted Critical
Publication of ATE189388T1 publication Critical patent/ATE189388T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT97904356T 1996-02-09 1997-01-24 Biologisch aktive ureido-derivate nützlich zur behandlung von multipler sklerose ATE189388T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9602721.4A GB9602721D0 (en) 1996-02-09 1996-02-09 Biologically active ureido derivatives useful in the treatment of multiple sclerosis
PCT/EP1997/000412 WO1997028796A1 (en) 1996-02-09 1997-01-24 Biologically active ureido derivatives useful in the treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
ATE189388T1 true ATE189388T1 (de) 2000-02-15

Family

ID=10788461

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97904356T ATE189388T1 (de) 1996-02-09 1997-01-24 Biologisch aktive ureido-derivate nützlich zur behandlung von multipler sklerose

Country Status (22)

Country Link
US (1) US5859046A (de)
EP (1) EP0820284B1 (de)
JP (1) JPH11504041A (de)
KR (1) KR19980703718A (de)
AR (1) AR005724A1 (de)
AT (1) ATE189388T1 (de)
AU (1) AU1720097A (de)
BR (1) BR9702075A (de)
CA (1) CA2217008A1 (de)
DE (1) DE69701243T2 (de)
DK (1) DK0820284T3 (de)
EA (1) EA000166B1 (de)
ES (1) ES2144844T3 (de)
GB (1) GB9602721D0 (de)
GR (1) GR3033332T3 (de)
HU (1) HUP9900796A2 (de)
IL (1) IL121808A0 (de)
NO (1) NO974651L (de)
PL (1) PL322717A1 (de)
PT (1) PT820284E (de)
WO (1) WO1997028796A1 (de)
ZA (1) ZA97902B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562859B1 (en) 1997-12-04 2003-05-13 The United States Of America As Represented By The Department Of Health And Human Services Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
US6348464B1 (en) 1999-11-12 2002-02-19 Guilford Pharmaceuticals, Inc. Pyrrolecarbonylimino derivatives as naaladase inhibitors
ATE433445T1 (de) 2003-03-03 2009-06-15 Eisai Corp North America Thiolactone als naaladase inhibitoren
EP3381897A1 (de) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivate des dinatrium 2,2'-{carbonylbis[imino-3,1-phenylencarbonylimino(1-methyl-1h-pyrrol-4,2-diyl)carbonylimino]}dinaphthalen-1,5-disulfonat salzes und verwandte verbindungen als heparanase inhibitoren zur behandlung von krebs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
GB9307948D0 (en) * 1993-04-16 1993-06-02 Erba Carlo Spa Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Also Published As

Publication number Publication date
GR3033332T3 (en) 2000-09-29
PL322717A1 (en) 1998-02-16
PT820284E (pt) 2000-07-31
ZA97902B (en) 1997-08-01
JPH11504041A (ja) 1999-04-06
AU1720097A (en) 1997-08-28
US5859046A (en) 1999-01-12
CA2217008A1 (en) 1997-08-14
ES2144844T3 (es) 2000-06-16
DE69701243D1 (de) 2000-03-09
NO974651D0 (no) 1997-10-08
MX9707673A (es) 1997-11-29
EA199700302A1 (ru) 1998-04-30
BR9702075A (pt) 1998-06-09
KR19980703718A (ko) 1998-12-05
AR005724A1 (es) 1999-07-14
EA000166B1 (ru) 1998-10-29
EP0820284A1 (de) 1998-01-28
NO974651L (no) 1997-12-02
EP0820284B1 (de) 2000-02-02
GB9602721D0 (en) 1996-04-10
HUP9900796A2 (hu) 1999-07-28
DK0820284T3 (da) 2000-07-24
DE69701243T2 (de) 2000-09-07
WO1997028796A1 (en) 1997-08-14
IL121808A0 (en) 1998-02-22

Similar Documents

Publication Publication Date Title
DE69711067T2 (de) Antikonvulsiva zur verwendung bei der behandlung von amyotropischer lateralsklerose
DE69427869D1 (de) Botulinumtoxine zur behandlung von hyperhydrosis
ATA46794A (de) Einrichtung zur behandlung von hautzonen
DE69730604D1 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
DE69603089T2 (de) Zusammensetzung zur behandlung von mauerwerk
DE69703649D1 (de) Behandlung von deagglomerierten teilchen mit plasmaaktivierter spezies
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
DE69527140T2 (de) Wirkstoff zur prävention oder behandlung von osteoporose
DE69433793D1 (de) Phosphorderivate zur behandlung von aids
IS4466A (is) Samsetning og meðhöndlun fyrir heila- og mænusigg
DE59707519D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE69716896D1 (de) Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression
DE59209268D1 (de) Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen
DE69734351D1 (de) Behandlung von zeitzonen in einem telekommunikationssystem
DE69721756D1 (de) Paroxetine zur behandlung von depression
DE69621447D1 (de) Verwendung von nitroflavonoide zur behandlung von angstzuständen
ATE204705T1 (de) Pflaster zur behandlung von pflanzen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE69701243D1 (de) Biologisch aktive ureido-derivate nützlich zur behandlung von multipler sklerose
DE69717846D1 (de) Behandlungsverfahren von laktamen
NO982582D0 (no) FremgangsmÕte for behandling av smerte
DE59308384D1 (de) Verfahren zur Behandlung von Gülle
DE69812599D1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE69806062D1 (de) Kombinationstherapie zur behandlung von aids
ATA93695A (de) Mittel zur behandlung von strahlenschäden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee